Literature DB >> 28833234

Mannose and fructose metabolism in red blood cells during cold storage in SAGM.

Óttar Rolfsson1,2, Freyr Johannsson1,2, Manuela Magnusdottir1, Giuseppe Paglia1,3, Ólafur E Sigurjonsson4,5, Aarash Bordbar6, Sirus Palsson6, Sigurður Brynjólfsson1, Sveinn Guðmundsson4, Bernhard Palsson1.   

Abstract

BACKGROUND: Alternate sugar metabolism during red blood cell (RBC) storage is not well understood. Here we report fructose and mannose metabolism in RBCs during cold storage in SAGM and the impact that these monosaccharides have on metabolic biomarkers of RBC storage lesion. STUDY DESIGN AND METHODS: RBCs were stored in SAGM containing uniformly labeled 13 C-fructose or 13 C-mannose at 9 or 18 mmol/L concentration for 25 days. RBCs and media were sampled at 14 time points during storage and analyzed using ultraperformance liquid chromatography-mass spectrometry. Blood banking quality assurance measurements were performed.
RESULTS: Red blood cells incorporated fructose and mannose during cold storage in the presence of glucose. Mannose was metabolized in preference to glucose via glycolysis. Fructose lowered adenosine triphosphate (ATP) levels and contributed little to ATP maintenance when added to SAGM. Both monosaccharides form the advanced glycation end product glycerate. Mannose activates enzymes in the RBC that take part in glycan synthesis.
CONCLUSIONS: Fructose or mannose addition to RBC SAGM concentrates may not offset the shift in metabolism of RBCs that occurs after 10 days of storage. Fructose and mannose metabolism at 4°C in SAGM reflects their metabolism at physiologic temperature. Glycerate excretion is a measure of protein deglycosylation activity in stored RBCs. No cytoprotective effect was observed upon the addition of either fructose or mannose to SAGM.
© 2017 AABB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28833234     DOI: 10.1111/trf.14266

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Metabolic effect of alkaline additives and guanosine/gluconate in storage solutions for red blood cells.

Authors:  Angelo D'Alessandro; Julie A Reisz; Rachel Culp-Hill; Herbert Korsten; Robin van Bruggen; Dirk de Korte
Journal:  Transfusion       Date:  2018-04-06       Impact factor: 3.157

Review 2.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

3.  Heterogeneity of blood processing and storage additives in different centers impacts stored red blood cell metabolism as much as storage time: lessons from REDS-III-Omics.

Authors:  Angelo D'Alessandro; Rachel Culp-Hill; Julie A Reisz; Mikayla Anderson; Xiaoyun Fu; Travis Nemkov; Sarah Gehrke; Connie Zheng; Tamir Kanias; Yuelong Guo; Grier Page; Mark T Gladwin; Steve Kleinman; Marion Lanteri; Mars Stone; Michael Busch; James C Zimring
Journal:  Transfusion       Date:  2018-10-24       Impact factor: 3.157

Review 4.  Systems biology as an emerging paradigm in transfusion medicine.

Authors:  James T Yurkovich; Aarash Bordbar; Ólafur E Sigurjónsson; Bernhard O Palsson
Journal:  BMC Syst Biol       Date:  2018-03-07

5.  Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer.

Authors:  Sigurdur Trausti Karvelsson; Qiong Wang; Bylgja Hilmarsdottir; Arnar Sigurdsson; Siver Andreas Moestue; Gunhild Mari Mælandsmo; Skarphedinn Halldorsson; Steinn Gudmundsson; Ottar Rolfsson
Journal:  NPJ Syst Biol Appl       Date:  2021-09-17

6.  UDP-glucose dehydrogenase expression is upregulated following EMT and differentially affects intracellular glycerophosphocholine and acetylaspartate levels in breast mesenchymal cell lines.

Authors:  Qiong Wang; Sigurdur Trausti Karvelsson; Freyr Johannsson; Arnar Ingi Vilhjalmsson; Lars Hagen; Davi de Miranda Fonseca; Animesh Sharma; Geir Slupphaug; Ottar Rolfsson
Journal:  Mol Oncol       Date:  2022-02-03       Impact factor: 7.449

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.